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ABSTRACT: 2-Deoxy-2-ﬂuoroglycosyl iodides are privileged
glycosyl donors for the stereoselective preparation of 1-Nu-β-
ﬂuorosugars, which are useful reagents for chemical site-selective
protein glycosylation. Ready access to such β-ﬂuorosugars
enables the mild and eﬃcient construction of well-deﬁned
ﬂuoroglycoproteins.
F-glycopeptides1−9 and the more recently disclosed F-
glycoproteins10−19 are promising candidates for the preparation
of synthetic carbohydrate vaccines20 and hold great potential as
a new generation of [18F]-(glyco)radiopharmaceuticals21,22 and
tracers for the noninvasive imaging techniques positron
emission tomography (18F-PET)23,24 and magnetic reso-
nance/magnetic resonance imaging (19F-MR/MRI).25 In
addition to the development of more eﬃcient methods for
protein/peptide modiﬁcation,26 it is also pivotal to access pure
F-sugar reagents and building blocks for such transformations.
These glycosyl units typically include in their structure reactive
handles such as azides (for copper(I)-catalyzed azide−alkyne
cycloaddition−CuAAC and Staudinger ligations)17 or chalc-
ogens in the form of sulfhydryl groups or diselenide moieties
(for exchange reactions with Cys or additions to dehydroala-
nine),14,15 which upon reaction generate a new carbohydrate−
protein conjugate. Retrosynthetic analysis revealed that 2-F-
glycosyl halides are suitable glycosyl donors for the preparation
of such reagents via biphasic glycosylations/phase-transfer
catalyzed reactions (PTC). These moieties enable exquisite
control of β-anomeric selectivity (via SN2-like mechanism)
during the introduction of the reactive handle, which is typically
a “soft” nucleophilic moiety.27 There are two general strategies
(one-pot from glycals vs two-step from 2-F-pyranoses) for the
preparation of 1-β-“soft Nu”-2-deoxy-2-ﬂuoroglycosides using
electrophilic F+ reagents (Scheme 1).28 While the one-pot
strategy works well for certain conﬁgurations (e.g., Gal), the
two-step approach is more general and thus preferred for the
preparation of pure F-sugar reagents in a more eﬃcient and
homogeneous manner (giving a better overall yield and
controlled Fax/eq diastereoselectivity).
Among glycosyl halides, iodides29 have been recently utilized
in several glycosylation strategies and provide a robust platform
for PTC reactions, perhaps leading to higher yields compared
to chlorides or bromides due to their superior leaving group
properties under SN2-like reaction conditions. There are very
few examples of 2-F- and 2,2-diF-glycosyl iodides. This rare
class of glycosyl donors include some isolated examples of 2-F-
and 2,2-diF-pyranosides30−32 and our 2-F-galactopyranosyl
iodide prepared via a “one-pot” strategy, as revealed by VT-
NMR experiments (see Supporting Information),33 and more
recently 2,2-diF-furanosides.34 Despite their great potential, low
preparative yields in the pyranose series and inseparable α/β
mixtures in the case of furanoses has so far hampered their wide
utilization as β-selective glycosyl donors in PTC protocols.
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Scheme 1. General Strategies for the Preparation of 1-β-
“Soft Nu”-2-deoxy-2-ﬂuoroglycosides Using F+
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In this work, we envisioned a “two-step” strategy for the
preparation of 2-F-glycosyl iodides from ready available 2-F-
glycosyl-1-O-Ac derivatives that might overcome such
limitations enabling a more eﬃcient preparation of this class
of highly reactive glycosyl donors. We then sought to explore
their reactivity for the preparation of ﬂuorosugar reagents that
would serve as useful moieties to achieve site-selective chemical
glycosylation of proteins. We ﬁrst evaluated the reaction
conditions using 2-F-α/β-galactopyranose 1 (Table 1). Initial
experiments revealed TMSI35 to be an eﬀective promoter for
the preparation of glycosyl iodide 2a, although the reaction
only proceeded in 57% yield after two consecutive reaction
cycles (entry 1). We found that addition of MgO36 that acts as
a scavenger for the in situ generated TMSOAc avoids the
reversible formation of starting 1, while increasing the yields up
to 78% (entry 2). Good yields (up to 85% in a single reaction
cycle) were ﬁnally obtained by increasing the amount of both
TMSI (2.2 equiv) and MgO (4 equiv) as well as reducing the
reaction temperature (from reﬂux to rt) in order to avoid
detrimental side reactions (entry 3). Other promoters were also
evaluated (entries 4−7). While the use of HMDS/I2 proved
ineﬀective and complex mixtures of products were observed
(entry 7),37 the in situ formation of highly reactive HI by
reﬂuxing AcSH and I2 allowed the formation of the desired
iodide 2a, albeit in lower yields compared to TMSI (up to
54%) (entries 4−6).38 Interestingly, the use of MgO was found
to be costly (24%) when using AcSH and I2 probably due to its
incompatibility with AcSH and/or HI (entry 4). 2-F-galactosyl
bromide 2b was also prepared following a reported procedure
in 95% yield (Table 1, entry 8).39 With the optimized
conditions in hand we set out to evaluate the scope of the
iodination with other conﬁgurations (Table 2). Conditions A
(with TMSI) were utilized with 2-F-α/β-pyranoses of Glc 3 and
Man 4 conﬁguration aﬀording desired glycosyl iodides 5a and
6a in moderate yields (entries 1 and 4). To our delight,
conditions B (with AcSH and I2) improved the yield to 82% for
5a and 75% for 6a (entries 2 and 5). 2-F-glycosyl bromides 5b
and 6b were also prepared in excellent yields (up to 98%) using
the standard conditions (entries 3 and 6). Practical yields of the
corresponding α-glycosyl iodides as sole anomers (e.g., 1JC1−H1
= 187.6 Hz, 3J1,2 = 4.7 Hz, and
3J3,4 = 10.2 Hz in 5a,
4C1
conformation)40 were obtained regardless of the pyranoside
conﬁguration (Gal, Glc, and Man).
2-F-glycosyl iodides proved stable and were puriﬁed by SiO2
ﬂash column chromatography with no decomposition observed.
They are also UV visible (at 254 nm) providing an easy
experimental follow-up. Similar to other protocols that use
strong acid activators (e.g., HBr), base sensitive acetyl groups
are the more appropriate protecting groups for the overall
synthetic route (Selectﬂuor−halogenation−PTC−deprotec-
tion). Acetyl protecting groups are easily introduced, prove
stable under the sequence of transformations, and are easily
removed under Zempleń conditions to aﬀord the ﬁnal
unprotected and ready-to-conjugate ﬂuorosugar reagents.
Other acid sensitive groups such as tert-butyldiphenylsilyl
(TBDPSi) were not tolerated under the optimized acid−based
reaction conditions, and extensive deprotection was observed.
Next, the synthesis of 1-β-“soft Nu”-2-deoxy-2-ﬂuoroglyco-
sides was attempted using 2-F-glycosyl halides 2a,b and 5−6a,b
(Scheme 2). A wide range of N-, S-, and Se-nucleophiles led to
β-ﬂuorosugar reagents 7−10, useful for chemical protein
glycosylation strategies,14,15,17 even including those with the
challenging 1-β-cis-Man41 disposition 9a−c. Excellent yields
(up to 98%) and pure β-selectivity (e.g., 1JC1−H1 = 162.7 Hz,
3J1,2 = 10.6 Hz, and
3J3,4 = 9.5 Hz in 8c,
4C1 conformation)
40
were always obtained. Iodides proved slightly better in terms of
yield (ca. 10−15%) over their bromide counterparts using a
better Nu in a “match” scenario of reactivity. We believe the
low reactivity of mannosyl-1-halides is probably due to
unfavorable dipolar interactions between the donor and the
incoming Nu and/or conformational issues that reduce the
reaction rate. This made competitive otherwise negligible side
reactions that reduce the overall yield.42 A weaker Nu such as
sodium benzenethiosulfonate (NaPTS)43 necessitated the use
of more reactive iodides and aﬀorded moderate-to-good yields
(88% for I vs 45% for Br in 10a). Our data indicate that 2-F-
glycosyl iodides are needed when using weaker nucleophiles.
The reported 2-F-glycosyl iodides may also ﬁnd broader utility
for example in the preparation of advanced ﬂuorinated building
blocks such as O-linked natural product mimetics44 11a and
covalent inhibitors45,46 of carbohydrate processing enzymes
11b and 12 where the use of “soft” nucleophilic acceptors are
required. Finally, to illustrate the application of such reagents
and further complement our previous reports on the
Table 1. Optimization of Reaction Conditions for the
Halogenation of 1a
entry conditions (equiv) product yield (%)
1 TMSI (1), rt, 8 h 2a 57b
2 TMSI (1.1), MgO (2), reﬂux, 12 h 2a 78b
3 TMSI (2.2), MgO (4), rt, 24 h 2a 85
4 AcSH (1.7), I2 (0.8), MgO (2), reﬂux, 30 h 2a 24
b
5 AcSH (4.4), I2 (2), reﬂux, 12 h 2a 34
b
6 AcSH (2.2), I2 (1), reﬂux, 12 h 2a 54
b
7 HMDS (0.6), I2 (0.6), rt, 24 h 2a mixture
8 33% HBr in AcOH, rt, 8 h 2b 95
aGeneral conditions: 2-F-α/β-galactopyranose 1 (2:1 α/β) (1 equiv)
in dry CH2Cl2 (0.1 M) unless otherwise indicated.
bIsolated yield after
two consecutive reaction cycles. TMS = trimethylsilyl, HMDS =
hexamethyldisilazane.
Table 2. Scope of Halogenationa
entry 2-F-pyranose conditions product yield (%)
1 3 A 5a 38b
2 3 B 5a 82b
3 3 C 5b 98
4 4 A 6a 50b
5 4 B 6a 75b
6 4 C 6b 94
aGeneral conditions: 2-F-α/β-pyranose (1:0−1:3 α/β) (1 equiv) in
dry CH2Cl2 (0.1 M) unless otherwise indicated.
bIsolated yield after
two consecutive reaction cycles. Conditions A: TMSI (2.2 equiv),
MgO (4 equiv), rt, 30 h. Conditions B: AcSH (2.2), I2 (1), reﬂux, 5 h.
Conditions C: 33% HBr in AcOH, rt, 3−8 h. TMS = trimethylsilyl.
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preparation of a variety of well-deﬁned triazole,17 thioether,15,18
and SeS-linked14,18 ﬂuorinated glycoproteins including their
[18F]-counterparts, we examined the reaction between Cys-
speciﬁc Ac3GlcF
9 and Ac3GalF-1-PTS reagents 10a,b with
Annexin V 13. This protein displays a unique naturally
occurring surface exposed Cys and is widely utilized as a
marker of apoptosis (Scheme 3).47 Indeed, reaction of 10a or
10b with Annexin V 13 in 20 mM Tris HCl buﬀer pH 8 and
10% CH3CN, which was used to ensure reagent solubility, gave
the expected homogeneous disulﬁde-linked F-glycoproteins
14a,b in >95% conversion after 1 h at rt. This is demonstrative
of the utility of the reagents that can now be easily prepared
from the 2-F-glycosyl iodide reagents we have reported in this
work. Moreover, this methodology is amenable to utilization in
18F-PET imaging using the corresponding [18F]-glyco-1-PTS
reagents.9
In summary, we have disclosed a general strategy for
accessing a wide range of 1-Nu-2-ﬂuorosugars that are useful
reagents for chemical-site-selective protein glycosylation. The
glycosyl iodide intermediates prepared here possess a seemly
balance between stability and reactivity that facilitates their
preparation, puriﬁcation, and storage. Importantly, these
intermediates also ensure product homogeneity by their
exquisite β-control during stereoselective glycosylation with a
“soft” Nu (via SN2-like reactions). The reported F-sugar
reagents will ﬁnd broad utility for building not only
homogeneous 19F- but also [18F]-glycoprobes that are valuable
tools in the ﬁelds of chemical biology and biomedical imaging.
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